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Abstract
Background: Rift Valley fever (RVF) is an acute febrile arthropod-borne viral disease of man and animals caused by
a member of the Phlebovirus genus, one of the five genera in the family Bunyaviridae. RVF virus (RVFV) is
transmitted between animals and human by mosquitoes, particularly those belonging to the Culex, Anopheles and
Aedes genera.
Methods: Experiments were designed during RVF outbreak, 2007 in Sudan to provide an answer about many
raised questions about the estimated role of vector in RVFV epidemiology. During this study, adult and immature
mosquito species were collected from Khartoum and White Nile states, identified and species abundance was
calculated. All samples were frozen individually for further virus detection. Total RNA was extracted from individual
insects and RVF virus was detected from Culex, Anopheles and Aedes species using RT-PCR. In addition, data were
collected about human cases up to November 24
th, 2007 to asses the situation of the disease in affected states.
Furthermore, a historical background of the RVF outbreaks was discussed in relation to global climatic anomalies
and incriminated vector species.
Results: A total of 978 mosquitoes, belonging to 3 genera and 7 species, were collected during Sudan outbreak,
2007. Anopheles gambiae arabiensis was the most frequent species (80.7%) in White Nile state. Meanwhile, Cx.
pipiens complex was the most abundant species (91.2%) in Khartoum state. RT-PCR was used and successfully
amplified 551 bp within the M segment of the tripartite negative-sense single stranded RNA genome of RVFV. The
virus was detected in female, male and larval stages of Culex and Anopheles species. The most affected human age
interval was 15-29 years old followed by ≥ 45 years old, 30-44 years old, and then 5-14 years old. Regarding to the
profession, housewives followed by farmers, students, shepherd, workers and the free were more vulnerable to the
infection. Furthermore, connection between human and entomological studies results in important human case-
vulnerability relatedness findings.
Conclusion: Model performance, integrated with epidemiologic and environmental surveillance systems should be
assessed systematically for RVF and other mosquito-borne diseases using historical epidemiologic and satellite
monitoring data. Case management related interventions; health education and vector control efforts are extremely
effective in preparedness for viral hemorrhagic fever and other seasonal outbreaks.
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Rift Valley fever (RVF) is an acute febrile arthropod-
borne viral disease of man and animals caused by a
member of the Phlebovirus genus, one of the five gen-
era in the family Bunyaviridae.R V Fv i r u s( R V F V )i s
transmitted between animals and human by mosqui-
toes, particularly those belonging to the Culex, Ano-
pheles and Aedes genera [1,2]. Transmission is mostly
horizontal, but a vertical mode was described for some
Aedes s p e c i e s[ 3 , 4 ] .R V F Vi sc a r r i e di nt h ee g g so f
Aedes mosquitoes which breed in isolated depressions
called dambos found in the vast grassland areas. At
flooding of the dambos during periods of extensive
and widespread rainfall, the eggs of the Aedes mosqui-
toes hatch and the subsequent adults transmit the
virus to domestic animals including sheep, goats, cat-
tle, camels, and buffalos [5]. These depressions also
serve as good habitats for Culex and Anopheles mos-
quito species. When Aedes mosquitoes infect domestic
animals with RVFV, virus amplification occurs in these
vertebrate hosts, leading to propagation into various
Culex and Anopheles species that are capable of trans-
mitting the virus to a wider area beyond the area of
t h eo r i g i n a lo u t b r e a k sb yw i n d - b o r n ed i s p e r s a l[ 6 ] .
Although RVFV is, in most cases, transmitted to
h u m a n sb ym o s q u i t o e s ,i tm a ya l s ob et r a n s m i t t e d
through direct contact with secretions of infected ani-
mals and meat. The professional nature of some
groups, such as doctors and veterinarians working in
slaughterhouses, made them more vulnerable than
others to infection (because the virus is not vital out-
side the body). Good cooking of meat may help to
eliminate the virus from it [7].
The disease in animals is characterized by high rates of
abortion and death of young ruminants [1]. Human dis-
ease symptoms are often limited to a flu-like syndrome
with transient fever, rigor (shivering), headache, severe
muscle and joint pains, photophobia and anorexia, some-
times with a petaechial rash, nausea, vomiting and epis-
taxis. The symptomatic course is 4 to 7 days leading to
full recovery in 2 weeks. However in severe cases, case
fatality rates are about 1% and usually associated with
hemorrhagic manifestations of the disease. Meningoence-
phalitis also occurs in about 1% of infections, but does
not usually result in death. Ocular sequellae occur in a
moderate percentage of cases and may result in impaired
vision or even blindness, which might be permanent [2].
Human cases are mainly caused by direct contact with
infected animal body fluids after abortion or slaughtering
viremic animals and by mosquito bites. When an epizoo-
tic occurs in animals, it is easily transmitted to humans
leading to an epidemic [8].
RVFV was first identified in 1931 during an investiga-
tion into an epizootic among sheep on a farm in the
Rift Valley of Kenya. Since then, outbreaks have been
reported in sub-Saharan and North Africa. Data pre-
sented in Table 1 described all previously reported
RVFV outbreaks after 1931. In 1950-51, a major epi-
zootic in Kenya caused 500,000 abortion and 100,000
deaths in sheep. In 1977, an epidemic of RVF was
recoded in Egypt. Cx. pipiens was incriminated in dis-
ease transmission and dissemination [9,10]. A major
outbreak occurred in Senegal in 1987 and 2003. Both
Cx. poicilipes and Ae. vexans were collected from the
affected sites [11]. In 1997-98, Faye et al.r e p o r t e da
major outbreak occurred in Eastern Africa (Cx. theileri),
Table 1 Historical background on the recorded outbreaks in Africa and Asia continents showing the year of outbreak,
country and incriminated arthropod species.
Year of outbreak Affected country Collected arthropods Reference
1997-98 and December 2006 Kenya Culex zombaensis, Anopheles coustani, Aedes mcintoshi*,
Mansonia africana, and M. uniformis
[8]
1997-98 and from January to May 2007 Tanzania Aedes mcintoshi* [12]
1997-1998 Eastern Africa, Culex theileri* [11]
1977 Egypt Culex pipiens* [9,10]
1987, 2003 Senegal Culex poicilipes* and Aedes vexans [11]
23 Oct 2000 Kingdom Saudi Arabia Culex pipiens complex, Aedes vexans arabiensis, Ae. Vittatus,
Ae. (Stegomyia) nilineatus, Aedes vexans arabiensis and Culex (culex)
triteniorynchus*
[13,14,16]
19 Oct 2000 Yemen Not defined [15]
1987, 1998 and October
2003
Mauritania An. pharoensis, rhodesiensis, rufipes, C. antennatus, decens, neavei,
perfuscus, poicilipes, quinquefasciatus*, Sandflies, Biting midges.
Culex poicilipes*, antennatus, Mansonia uniformis (2003)
[11,34,35]
Oct, 2007 to Jan, 2008 Sudan. Culex pipiens complex, Anopheles gambae arabiensis*, Ae. aegypti. [8,36]
1997-98 and Dec 2006 to Feb 2007 Somalia Not defined [12]
*Most abundant species in the collection.
Seufi and Galal BMC Infectious Diseases 2010, 10:65
http://www.biomedcentral.com/1471-2334/10/65
Page 2 of 8Kenya (C x .z o m b a e n s i s ,A n .c o u s t a n i ,A e .m c i n t o s h i ,M .
africana, and M. uniformis), Somalia, Mauritania (An.
pharoensis, An. rhodesiensis, An. rufipes, Cx. antennatus,
Cx. decens, Cx. neavei, Cx. perfuscus, Cx. poicilipes,
Cx. quinquefasciatus, Sandflies, Biting midges) and Tan-
zania (Ae. mcintoshi) [11]. Mauritania registered another
outbreak in 2003. Cx. poicilipes, Cx. antennatus,a n dM.
uniformis were incriminated in disease transmission
[11]. Additional major outbreak was recorded in Kenya,
Tanzania, Sudan and Somalia [8,12]. In September 2000,
RVF cases were confirmed in Saudi Arabia (Cx. pipiens
complex, Ae. vexans arabiensis, Ae. Vittatus, Ae. (Stego-
myia) nilineatus and Cx. (cx.) triteniorynchus)a n d
Yemen, marking the first reported occurrence of the
disease outside the African continent and raising con-
cerns that it could extend to other parts of Asia and
Europe [13-15]. During these multiple outbreaks and
epidemics, the virus exhibited an amazing flexibility
to adapt to different ecological contexts and to take
advantage of climatic change and environmental disrup-
tions (dam building, land irrigation, etc.). Such an adap-
tive ability resulted in a high toll of deaths, ailments
and economic losses during its recent emergence
episodes [16].
Since livestock immunization against RVF has so far
appeared difficult to implement efficiently in areas of
endemicity, strengthened surveillance, early detection,
management of cases seemed to be among the best
options to prevent extension of RVF epidemic foci. Pre-
cise estimation of specific weight for each risk factor is
a considerable guide to construct an effective outbreak
control plan. Insufficient entomological studies and sur-
veys were conducted and resulted in a vague evaluation
of the vector role in RVFV transmission and dissemina-
tion in Sudan. For that reasons, this study was con-
ducted to answer some raised questions about the role
of vector(s) in RVFV outbreak, 2007 in Sudan.
Methods
Insect collection and identification
Adult and immature stages of mosquitoes were collected
on December 2007 from their breeding sites in White
Nile (affected) and Khartoum (not affected) states. Adults
were collected using CO2-baited light traps and aspirators
while immature stages were collected by sieving potential
larval habitats with dippers. 476 and 502 mosquitoes
were collected from White Nile and Khartoum states,
respectively. All specimens were identified at Sudan’s
National Health Laboratory. Mosquitoes were pooled
concerning their site of collection, species, sex and stage
(larva, pupa or adult). Mosquitoes were then frozen for
further virus detection. In both collection sites, livestock
(sheep, goats, cattle, camels and cows) were housed at
night in very close contact to their owners.
Molecular detection of RVFV in mosquitoes
RNA extraction
Total RNA was extracted from individual insects using
RNeasy kit according to manufacturer’s instructions
(QIAGEN). The RNA was dissolved in DEPC-treated
water, quantified spectrophotometrically and analyzed
on 1.2% agarose gel.
Reverse transcription of RNA
For synthesis of first strand cDNA, reverse transcription
reactions were performed using oligo dT primer (5’-
TTTTTTTTTTTTTTT-3’). Each 25 μl reaction mixture
containing 2.5 μlo f5 ×b u f f e rw i t hM g C l 2,2 . 5μlo f2 . 5
mM dNTPs, 1 μg of primer, 2 μg RNA, 200 U reverse
transcriptase enzyme. RT-PCR amplification was per-
formed in a thermal cycler (Eppendorf) programmed at
42°C for 1 hr, 72°C for 10 min. cDNA was then stored
at -20°C until used.
PCR amplification using RVFV specific primer set
Total PCR reaction volume of 25 μl containing 10 mM
Tris HCl (pH 8.3), 25 mM KCI, 4 mM MgCl2, 200 μM
dNTPs, 1 U Taq DNA polymerase (AmpliTaq, Perkin-
Elmer), 2 μl of the 10 pmol primer and 1 μl of the product
of reverse transcriptase reaction was employed. PCR
primers for this assay (Fwd: 5’-GAC TAC CAG TCA GCT
CAT TAC C-3’ and Rev: 5’-TG TGA ACA ATA GGC
ATT GG-3’) were designed to anneal to G2 glycoprotein
region within the M segment of the tripartite negative-
s e n s es i n g l es t r a n d e dR N Ag e n o m eo fR V F V .P C R
reaction was cycled first in a 9700 thermal cycler (Perkin-
Elmer) programmed at 94°C for 5 min (one cycle), then
followed by 40 cycles at 94°C for 15 s, 50°C for 15 s, and
72°C for 30 s. Reaction was then incubated at 72°C for 10
min for final extension [17]. Two μlo fl o a d i n gd y ew e r e
added prior to loading of 10 μl per gel pocket. Electro-
phoresis was performed at 80 Volt with 0.5 × TBE buffer
in 1.5% agarose gel. Gel was stained in 0.5 μg/ml (w/v)
ethidium bromide solution. Finally, gel was visualized and
photographed by using gel documentation system.
Human studies
Case definitions
A suspected human RVFV case-patient was defined as a
person with fever associated or not with hemorrhagic
jaundice, neurological symptoms or any person who
died with overt hemorrhagic fever symptoms from
October through December 2007. A confirmed human
RVFV case-patient was defined by more than one of
these laboratory tests: immunoglobulin M (IgM), RT-
PCR or virus isolation positive results.
Human investigations
In affected areas, the investigation was conducted under
the supervision of the chief of the sanitary district. For
each case, blood samples were collected and an inter-
view in which information was gathered about sex, age,
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toms for all case-patients and their contacts. All data of
human studies were kindly supported by the Sudan’s
National Health Laboratory, Department of Epidemiol-
ogy at the Federal Ministry of Health, Sudan
government.
Historical background on RVFV outbreaks
Outbreaks of RVFV were followed up through publica-
tions and reports. Table 1 presented a complete history
of the reported epizootics of RVFV, including the year
of outbreak, affected countries, collected arthropods that
were incriminated in disease transmission and dissemi-
nation and the reference reporting the epizootics.
Results
Entomological results
A total of 978 mosquitoes, belonging to 3 genera and 7
species, were collected (Tables 2 and 3). Among the spe-
cies collected from White Nile state, Anopheles gambiae
arabiensis was the most frequent species (80.7%),
followed by Culex pipiens complex (8.8%), Aedes aegypti
(5.0%), An. coustani (2.9%), Cx. poicilipes (1.7%), then
both Ae. mcintoshi and Ae. vexans (0.4%). Meanwhile,
Cx. pipiens complex was the most abundant species
(91.2%) collected from Khartoum state, followed by Cx.
poicilipes (4.4%), An. gambiae arabiensis (3.2%), An.
coustani (0.8%) and Ae. mcintoshi (0.4%). Neither Aedes
aegypti nor Ae. vexans was collected from Khartoum.
Overall, Cx. pipiens complex was more abundant than
An. gambiae arabiensis. Immature and adult species col-
lected from the two sites are presented in Tables 2 and
3. A total of 26 monospecific pools were constituted
regarding to species, stage and site of collection. Indivi-
dual mosquitoes were then submitted to RT-PCR assay
for RVFV detection.
RT-PCR amplification using RVFV specific primer set
Two oligonucleotide primers were designed to amplify
551 bp within the M segment of the tripartite negative-
sense single stranded RNA genome of RVFV [17], and
Table 2 A key table indicates the collected species number, stage, abundance and positive RT-PCR samples from
White Nile state.
Species Total no. of collected species Stage Species abundance* No. of positive PCR samples
Larva Pupa Male Female
An. gambiae arabiensis 384 28 4 30 322 80.7% 3L+2 M+26F** = 31
An. coustani 14 2 - 2 10 2.9% 1L+2F = 3
Cx. pipiens complex 42 22 4 - 16 8.8% 4L+1F*** = 5
Cx. poicilipes 8 6 - - 2 1.7% 1F = 1
Ae. aegypti 24 22 - - 2 5.0% 8L+2F**** = 10
Ae. mcintoshi 2 - - - 2 0.4% 0
Ae. vexans 2 2 - - - 0.4% 0
Total 476 82 8 32 354 100% 50
* Abundance = number of individuals of one species/total number of mosquitoes collected (approximated to one decimal).
** 24 gravid + 2 ungravid females.
*** Gravid females.
**** Ungravid female.
Table 3 A key table indicates the collected species number, stage, abundance and positive RT-PCR samples from
Khartoum state.
Species Total no. of collected species Stage Species abundance* No. of positive PCR samples
Larva Pupa Male Female
An. gambiae arabiensis 16 16 - - - 3.2% 2L = 2
An. coustani 4 2 - - 2 0.8% -
Cx. pipiens complex 458 446 - 4 8 91.2% 22L+2F** = 24
Cx. poicilipes 22 16 2 - 4 4.4% -
Ae. aegypti - - - - - 0.0 -
Ae. mcintoshi 2 2 - - - 0.4% -
Ae. vexans - - - - - 0.0
Total 502 482 2 4 14 100% 26
* Abundance = number of individuals of one species/total number of mosquitoes collected (approximated to one decimal).
** Ungravid female.
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lysis of the RT-PCR product on agarose gels revealed
that the primers amplified a single band of expected size
of 551 bp only in the RNA extracted from RVF-infected
samples. PCR mix with no template was used as nega-
tive control (Fig. 1). RVFV was successfully detected in
larvae and females of An. gambiae arabiensis, An. cous-
tani, Cx. pipiens complex and Ae. aegypti collected from
White Nile state (Table 2). Infection rate was estimated
as (31/476) 6.5, (3/476) 0.6, (5/476) 1.1 and (10/476)
2.1%, respectively. No virus was detected in either Ae.
mcintoshi or Ae. vexans, while only one female of Cx.
poicilipes was tested positive for RVFV collected from
White Nile state (Table 2). In parallel, RVFV was suc-
cessfully detected in both larvae and females of Cx.
pipiens complex and Cx. poicilipes collected from Khar-
toum state (Table 3). Infection rate was estimated as
(20/502) 4 and (4/502) 0.8%, respectively. No virus was
detected in Ae. mcintoshi collected from Khartoum
state. Two larvae, one of An. gambiae arabiensis and
one of An. coustani were tested positive for RVFV col-
lected from Khartoum state (Table 3). It is noteworthy
to mention that only two male samples of An. gambiae
arabiensis were tested positive for RVFV collected from
White Nile state (Table 2).
Human results
The different cases recorded in the affected states
(White Nile, Gazira and Sinnar) from the first onset up
to Nov 24
th, 2007 are presented in Table 4. Gazira state
hospitals received the highest number of suspected cases
(287/451), followed by White Nile (111/451) and Sinnar
(53/451) states. The cumulative number of deaths was
arranged in the same order. The first cases appeared in
southern areas of Algabalain locality in White Nile state
at October 4
th, 2007. According to the doctors and
citizens in that area, the first symptoms were hemor-
rhage and fever with rapid death. All reported cases in
the beginning of the outbreak were scattered and did
not reach any health facilities. After that the cases
started to be reported from Sinnar then Gazira states. It
was observed that the number of infections and subse-
quent deaths were more frequent in males than females
(Table 5). The most affected age interval was 15-29
years old followed by ≥ 45 years old, 30-44 years old,
and then 5-14 years old. Regarding to the profession,
housewives followed by farmers, students, shepherd,
w o r k e r sa n dt h ef r e ew e r em o r ev u l n e r a b l et oi n f e c t i o n
than others (Table 5). Majority of cases appeared with
hemorrhagic symptoms. 2-5% of all cases exhibited eye
complications and 1% exhibited meningococcal meningi-
tis. From the 451 reported case patients, 74 blood sam-
ples were submitted to ELISA and 5 samples to real
time PCR investigation. Only 30 samples of ELISA and
one sample of PCR were tested positive (Table 4). The
overall case-fatality rate (CFR) was estimated as 42.8%
in regard to the 451 reported cases (Table 4). Regarding
to the fact that the case-fatality rate for infections with
RVFV in humans is about 1%, the expected population
infected with RVFV is 19303 cases.
Discussion and Conclusions
This work was developed by an expert Egyptian team on
request of the Sudanese Federal Ministry of Health and
the author (A.S.) was one of this team.
The low diversity of the mosquito species collected in
this survey may be due to natural abundance of mos-
quito species (high abundance of Culex and Anopheles
Figure 1 1·5% agarose gel electrophoresis showing RT-PCR
product (551 bp) of RVFV in infected mosquitoes. Lanes M, 1, 2
and 3 show PhiX174 HaeIII DNA marker, 551 bp amplified product
from RVFV-infected mosquito, PCR mix without DNA (as negative
control) and ELISA positive mosquito (as positive control),
respectively.
Table 4 Epidemiological situation of human cases
recorded in the affected states up to Nov 24
th, 2007.
State Cumulative Laboratory results
Cases Deaths CFR%* Total samples Positive cases
ELISA PCR
White Nile 111 65 58.6 27+2 11/27 0/2
Gazira 287 113 39.4 34+3 15/34 1/3
Sinnar 53 15 28.3 13 4/13 -
Total 451 193 42.8 74+5 30/74 1/5
*CFR: Case Fatality Rate (approximated to one decimal).
Cumulative cases, deaths, case fatality rate in relation to laboratory results are
shown.
Table 5 Relationship between RVFV infection and some
observed parameters among 451 cases.
Parameter <5 years 5-14 y 15-29 y 30-44 y > 45 years
Age 2 32 159 120 138
Gender 290 ♀ 161 ♀
Profession* 128 HW 100 F 66 S 38 Sh 21 Free 73 Others
*HW: housewives, F: Farmer, S: Student and Sh: Shepherd.
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captures were undertaken at the end of the rainy season,
when most breeding sites had dried up and/or due to
the intensive use of pesticides to control blood sucking
insect vectors during outbreak. This hypothesis was
further strengthened by the small number of mosquitoes
caught (978) and the low number of Aedes mosquitoes,
a vector species of RVFV in West Africa [18]. Among
all adult and immature mosquito stages collected, Cx.
pipiens complex (51.1%) and An. gambiae arabiensis
(40.9%) were the most represented species. Most of the
collected mosquito species, especially Culex species [19],
were previously incriminated in RVFV transmission and
dissemination (Tables 1, 2 and 3). In addition, feeding
preference studies showed that Cx. pipiens fed preferen-
tially on pigeons but also on human at indoors. How-
ever, Anopheles species fed preferentially on human but
also on other mammals. These considerations on Culex
and Anopheles biology and ecology as well as its experi-
mentally demonstrated vectorial competence to RVFV
(Table 1) constituted clues pointing to their relative role
in RVFV transmission cycles. Excluding gravid females
(to avoid false positive results), the relative role of An.
gambiae arabiensis in transmission of RVFV in White
Nile and Khartoum states was 1.5% and 0.4%, respec-
tively. Meanwhile, the relative role of Cx. pipiens com-
plex in transmission of RVFV was 0.8% and 4.8% in
White Nile and Khartoum states, respectively. In case of
White Nile state, the relative roles of An. coustani, Cx.
poicilipes and Ae. aegypti were 0.6, 0.2 and 2.1%, respec-
t i v e l y .H i g hr e l a t i v er o l ei nc a s eo fAe. aegypti may be
attributed to the high number of positive detections in
relation to the number of collected samples. Although
the choice of a 1-month period, for monitoring mos-
quito natural abundance is quite a short time, it was
assumed to be a critical period for RVFV outbreak. In
addition, we were quite a bit late in the transmission
season and tried to follow up the outbreak as soon as
we could launch it.
RT-PCR assay is considered as specific, sensitive tool
for RVF diagnosis in the early phase of the disease and
its results do not differ significantly from those obtained
by virus isolation [20]. Successful RT-PCR detection of
RVFV in female mosquito species was considered as a
precursor for viral circulation in these species (incrimi-
nated in dissemination or acquired the virus in its mid-
gut only). Meanwhile, successful RT-PCR detection of
RVFV in male and larval stages, although at very low
rates, referred to transovarial (vertical) transmission of
the virus within these mosquito species. It may also
refer to possible venereal RVFV transmission when a
male being infected vertically and then infecting the
female during mating. RVFV was known to be carried
in the eggs of Aedes mosquitoes which can survive
for several years in the dried mud [21]. These mosqui-
toes breed in isolated depressions called dambos
found in the vast grassland areas. On flooding, Culex
mosquito species (bread in dambos) play important role
in virus circulation [22,23]. The survival of RVFV during
interepizootics was believed to depend on transovarial
transmission of the virus in floodwater Aedes mosqui-
toes [4].
Satellite monitoring (June-September, 2007) showed
that most of the central Sudan could be unusually sub-
jected to heavy rainfall, and generated RVF risk warn-
ings for central and southern Sudan in July-September.
In late October, RVF outbreaks were reported by World
Health Organization (WHO) in humans in Sudan in
White Nile, Sinnar, and Gazira states. By early Novem-
ber 2007, 329 human cases, including 96 deaths were
reported. The cases being reported in Gazira State are
in an area close to irrigation canals and are linked to
naturally occurring cycles involving livestock and mos-
quitoes which are abundant in the irrigation zone. In
parallel, many previously studied outbreaks were
reported to occur during heavy rainfall seasons in var-
ious sub-Saharan countries including Kenya, Somalia,
Tanzania, Senegal, Eastern Africa, Mauritania, Egypt and
more recently in Saudi Arabia and Yemen. Earlier works
suggested that epizootics and epidemics of RVFV occur
periodically after heavy rains that flood natural depres-
sions in the grasslands of sub-Saharan Africa [24,25]. In
addition to three outbreaks recorded in neighboring
countries (Table 1), Sudan was subjected to the heaviest
rainfall season reported in the last forty years. Given the
wide geographic and ecological range of RVFV, it is
necessary to monitor large areas for conditions that may
trigger the emergence of mosquito vectors that could
spread RVF. Furthermore, there has been increased scien-
tific interest in the connection between global climatic
anomalies and disease outbreaks [26]. RVFV is one exam-
ple of a disease whose outbreaks have been shown to be
closely coupled with climate anomalies [25].
Overall connection between human and entomological
results with regard to recorded outbreaks in neighboring
countries were definite warnings for the incoming RFV
outbreak in Sudan, especially that conditions of emer-
ging epidemics were almost certain. Furthermore, the
potential of RVF as a disease emerging in new areas was
first documented in Egypt in 1977 [2], and since then,
epidemics have occurred in Mauritania (1987 to 1988
and 1998), Madagascar (1990 to 1991), Egypt (1993),
and eastern Africa (in Kenya, Somalia, and Tanzania)
[27,28]. Recently, the outbreak on the Arabian Peninsula
(in Yemen and Saudi Arabia) represented the first case
of RVF outside Africa [29,30].
Although virus isolation (VI) is considered as gold
standard method, IgM-ELISA method avoids false
Seufi and Galal BMC Infectious Diseases 2010, 10:65
http://www.biomedcentral.com/1471-2334/10/65
Page 6 of 8positive results due to the presence of rheumatoid factor
and antinuclear antibodies. On the other hand, anti-RVF
IgM antibodies were estimated to persist at a detectable
level for up to 6 months in chronic infections [31].
However, combination of ELISA and RT-PCR assays is
very important for rapid and efficient identification of
RVFV during outbreaks. The present data and those
obtained during the epidemics of RVF in Mauritania
[11], in Kenya [32], as well as in Saudi Arabia and
Yemen [33] demonstrated the importance of combining
diagnostic assays for accurate and comprehensive detec-
tion of RVFV infection. The present results indicated
that males of 15-29 years old were more susceptible
than females. In parallel, housewives and farmers were
the most susceptible people to RVFV infection (Table
5). These results may be related to their more vulner-
ability to the vector as well as to socioeconomic/profes-
sional activities which allow a direct contact with
infected animals. Agreeable results were presented by
Woods et al. [32] who stated that children <15 years of
age were significantly less likely to have had recent
RVFV infection. A relation between virus infection and
direct contact with animals was reported by Faye et al.
[11]. Indeed, those at highest risk include butchers and
others who come in contact with animals (e.g., slaugh-
terhouse workers, tanners, and herdsmen), who repre-
sent a large part of the population living in these areas.
Although WHO estimated that the human mortality
rate due to RVFV is ≈1%-2% of infected patients, the
number of recorded deaths during this outbreak was
193 among 451 infected patients when the laboratory
data were considered exclusively. This means that the
number of infected but not officially recorded is about
19303 cases.
Conclusively, the present work reported that Culex
and Anopheles were collected in relatively high numbers
during Sudan outbreak, 2007. Because the mere pre-
sence of a mosquito species during the outbreak does
n o tm e a nt h a ti ti si n v o l v e di nt r a n s m i s s i o nc y c l eo f
RVFV, RT-PCR was used and successfully detected
RVFV in female, male and larval stages of Culex and
Anopheles species. Furthermore, connection between
human and entomological studies results in important
human case-vulnerability relatedness findings. It is note-
worthy that validated RVF forecast models may provide
early warning (~3 months) for RVF epidemics in Africa.
Model performance, integrated with epidemiologic and
environmental surveillance systems, should be assessed
systematically for RVF and other mosquito-borne dis-
eases using historical epidemiologic and satellite moni-
toring data. Case management related interventions;
health education and vector control efforts are extre-
mely effective in preparedness for viral haemorrhagic
fever and other seasonal outbreaks. Further confirmatory
transmission studies are very important to determine
the vectorial capacity of the incriminated species in this
study.
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